出版：Astute Analytica（アステュートアナリティカ） 出版年月：2022年7月
世界のバイタルサイン監視デバイス市場 : 測定パラメータ (酸素、血圧、温度)、用途 (集中治療、獣医学、その他)、フォーム ファクタ ［ポータブル、コンパクト (卓上)、モジュラー、その他］、エンドユーザー (病院、診療所、外来センター、その他) 、評価と予測 2017-2030 年
Global Vital Signs Monitoring Devices Market, By Measuring Parameters (Oxygen, Blood Pressure, Temperature), By Application (Intensive Care, Veterinary, Others), By Form Factor (Portable, Compact (Tabletop), Modular, Others), By End User (Hospitals, Clinics, Ambulatory Centers, Others), Estimation & Forecast, 2017 – 2030
| ページ数 | 224 |
| 価格 | |
| シングルユーザライセンス | USD 4,250 |
| サイトライセンス | USD 5,250 |
| エンタープライズライセンス | USD 6,400 |
| 種別 | 英文調査報告書 |
Market Introduction
The global vital signs monitoring devices market held a market value of USD 4,960.0 Million in 2021 and is estimated to reach USD 8,126.0 Million by the year 2030. The market is projected to list a CAGR of 5.8% during the forecast period.
The vital signs monitoring devices industry is projected to grow at a substantial rate owing to the increasing incidences of chronic and acute diseases, and the rising innovations in area. Moreover, the rising elderly population around the globe contributes substantially towards the rise in the growth rate of the vital signs monitoring devices market. For instance, according to the World Health Organization (WHO), the geriatric population worldwide (aged 60 years and above) is projected to reach around 2 Billion by 2050. Thus, such actions contribute towards the growth rate.
The increasing launches of novel devices and its cost effectiveness is also boosting the market growth. The increasing product launches is a lucrative opportunity for the market growth, and is anticipated to contribute significantly for the growth of the vital signs monitoring devices marketspace.
However, the market is likely to be negatively influenced by the high availability of alternative vital signs monitoring devices. Furthermore, the competitive pricing models is also expected to hinder the market growth.
Growth Influencers:
Increasing incidence rate of chronic diseases
The increasing incidence rates and prevalence of diseases such as CVD, neurological disorders, and cancer are creating huge demand for the adoption of vital signs monitoring systems which in turn increases the demand for advanced system which allows healthcare provider to decrease the time taken and assist in providing treatment at an appropriate time. For instance, according to the World Health Organization, the major diseases that lead to the most deaths from noncommunicable diseases (NCDs) are cardiovascular diseases, cancers, respiratory diseases and diabetes, accounting for more than 80% of all premature NCD deaths. Thus, such statistics aid the demand and growth of the market.
Technological advancement and innovation of new devices
The increase in point of care devices that are accessible to patients from all age groups is driving the market growth. For instance, in April 2021, A&D Company launched a new product in response to the international standard ISO80369 series, home-use brachial blood pressure monitor “A & D Plus series “. Thus, such innovative product launches propel the market growth.
Segments Overview:
The global vital signs monitoring devices market is segmented into measuring parameters, application, form factor and end user.
By Measuring Parameters,
• Oxygen
• Blood Pressure
• Temperature
• ECG
• Carbon dioxide
• Respiratory
• Heart Rate
• Blood Glucose
• Cardiac output
• Others
The oxygen segment is projected to hold the highest growth rate of 7% over the forecast period. Moreover, the blood pressure segment held the largest market share of more than 25% in 2021. In addition to that, the ECG segment is estimated to cross the mark of USD 1,000 Million revenue by 2028.
By Application,
• Intensive Care
• Veterinary
• Ambulatory
• Emergency
• Clinical
• Transport
• Anesthesia
• Others
The intensive care segment is anticipated to grow at the highest CAGR of 6.7% owing to the increased applications of vital sign monitors in this setting. In addition to that, the ambulatory segment is estimated to hold an opportunity of more than USD 700 Million during 2021 to 2030. Moreover, the transport segment is projected to cross the mark of USD 500 Million revenue by 2024.
By Form Factor,
• Portable
o Handheld
o Wearable
• Compact (Tabletop)
• Modular
• Floor standing
• Tunnel
The portable segment held the largest market share of more than 30% in 2021, whereas the modular segment is projected to hold an opportunity of more than USD 750 Million during 2021-2030.
By End User,
• Hospitals
• Clinics
• Ambulatory Centers
• Home Healthcare
• Veterinary Clinics
The ambulatory centers segment held the highest growth rate of 6.6% over the forecast period owing to the rise in ambulatory services, and the usage of top-notch vital sign monitors in ambulances.
Regional Overview
By region, the global vital signs monitoring devices market is divided into North America, Asia Pacific, Europe, Middle East & Africa, and South America.
The North America region held the largest market share of more than 35% owing to the increasing strategic as well as research developments by the companies operating in the marketspace. The Asia-Pacific region is projected to grow steadily owing to the increasing population in countries like China and India.
The European region is anticipated to grow at a steady rate owing to the rising awareness regarding newer launches. Moreover, the Middle Eastern and African region is also expected to grow at a substantial rate.
Competitive Landscape
The prominent players operating in the global vital signs monitoring devices market include A&D Company Ltd., Clarity Medical Pvt. Ltd., Contec Medical Systems Co. Ltd, DRE Inc., GE Healthcare, Hill-Rom Holdings, Inc., Koninklijke Philips N.V., Masimo Corporation, Mediaid, Inc., Medtronic plc., Nihon Kohden Corporation, Nonin Medical Inc., Omron Healthcare, Smiths Group plc., SunTech Medical, Inc.
The prominent four players in the market hold approximately 15% of the market share. These market players are investing in collaborations, product launches, mergers, acquisitions, expansions, in order to produce a competitive edge against their counterparts. For instance, in December 2021, Philips received FDA 510(k) clearance for its most advanced acute patient monitors. Philips Patient Monitors IntelliVue MX750 and IntelliVue MX850 pair with advanced software and services to offer clinical decision support.
The global vital signs monitoring devices market report provides insights on the below pointers:
• Market Penetration: Provides comprehensive information on the market offered by the prominent players
• Market Development: The report offers detailed information about lucrative emerging markets and analyzes penetration across mature segments of the markets
• Market Diversification: Provides in-depth information about untapped geographies, recent developments, and investments
• Competitive Landscape Assessment: Mergers & acquisitions, certifications, product launches in the global vital signs monitoring devices market have been provided in this research report. In addition, the report also emphasizes the SWOT analysis of the leading players.
• Product Development & Innovation: The report provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
• Pricing Analysis: Pricing analysis of various metals and other components used in the manufacturing of vital signs monitoring devices products
• Manufacturing Cost Analysis: Cost-share of various components in vital signs monitoring devices tools
The global vital signs monitoring devices market report answers questions such as:
• What is the market size and forecast of the global vital signs monitoring devices market?
• What are the inhibiting factors and impact of COVID-19 on the global vital signs monitoring devices market during the assessment period?
• Which are the products/segments/applications/areas to invest in over the assessment period in the global vital signs monitoring devices market?
• What is the competitive strategic window for opportunities in the global vital signs monitoring devices market?
• What are the technology trends and regulatory frameworks in the global vital signs monitoring devices market?
• What is the market share of the leading players in the global vital signs monitoring devices market?
• What modes and strategic moves are considered favorable for entering the global vital signs monitoring devices market?
目次
Chapter 1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
Chapter 2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Region
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation
Chapter 3. Executive Summary: Global Vital Signs Monitoring Devices Market
Chapter 4. Global Vital Signs Monitoring Devices Market Overview
4.1. Industry Value Chain Analysis
4.1.1. Component Suppliers
4.1.2. Manufacturer
4.1.3. Distributor
4.1.4. End-User
4.2. Industry Outlook
4.3. PESTLE Analysis
4.4. Porter’s Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2017 – 2030
4.7.2. Market Volume Estimates and Forecast (000’Units), 2017 – 2030
4.7.3. Pricing Analysis
4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2020
4.8.3. Competitor Mapping
Chapter 5. Global Vital Signs Monitoring Devices Market, By Measuring Parameters
5.1. Key Insights
5.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
5.2.1. Oxygen
5.2.2. Blood Pressure
5.2.3. Temperature
5.2.4. ECG
5.2.5. Carbon dioxide
5.2.6. Respiratory
5.2.7. Heart Rate
5.2.8. Blood Glucose
5.2.9. Cardiac output
5.2.10. Others
Chapter 6. Global Vital Signs Monitoring Devices Market, By Application
6.1. Key Insights
6.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
6.2.1. Veterinary
6.2.2. Ambulatory
6.2.3. Emergency
6.2.4. Clinical
6.2.5. Transport
6.2.6. Anesthesia
6.2.7. Others
Chapter 7. Global Vital Signs Monitoring Devices Market, By Form Factor
7.1. Key Insights
7.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
7.2.1. Portable
7.2.1.1. Handheld
7.2.1.2. Wearable
7.2.2. Compact (Tabletop)
7.2.3. Modular
7.2.4. Floor standing
7.2.5. Tunnel
Chapter 8. Global Vital Signs Monitoring Devices Market, By End User
8.1. Key Insights
8.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
8.2.1. Hospitals
8.2.2. Clinics
8.2.3. Ambulatory Centers
8.2.4. Home Healthcare
8.2.5. Veterinary Clinics
Chapter 9. Global Vital Signs Monitoring Devices Market Analysis, By Region
9.1. Key Insights
9.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
9.2.1. North America
9.2.1.1. The U.S.
9.2.1.2. Canada
9.2.1.3. Mexico
9.2.2. Europe
9.2.2.1. Western Europe
9.2.2.1.1. The UK
9.2.2.1.2. Germany
9.2.2.1.3. France
9.2.2.1.4. Italy
9.2.2.1.5. Spain
9.2.2.1.6. Rest of Western Europe
9.2.2.2. Eastern Europe
9.2.2.2.1. Poland
9.2.2.2.2. Russia
9.2.2.2.3. Rest of Eastern Europe
9.2.3. Asia Pacific
9.2.3.1. China
9.2.3.2. India
9.2.3.3. Japan
9.2.3.4. Australia & New Zealand
9.2.3.5. ASEAN
9.2.3.6. Rest of Asia Pacific
9.2.4. Middle East & Africa (MEA)
9.2.4.1. UAE
9.2.4.2. Saudi Arabia
9.2.4.3. South Africa
9.2.4.4. Rest of MEA
9.2.5. South America
9.2.5.1. Brazil
9.2.5.2. Argentina
9.2.5.3. Rest of South America
Chapter 10. North America Vital Signs Monitoring Devices Market Analysis
10.1. Key Insights
10.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
10.2.1. By Measuring Parameters
10.2.2. By Application
10.2.3. By Form Factor
10.2.4. By End User
10.2.5. By Country
Chapter 11. Europe Vital Signs Monitoring Devices Market Analysis
11.1. Key Insights
11.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
11.2.1. By Measuring Parameters
11.2.2. By Application
11.2.3. By Form Factor
11.2.4. By End User
11.2.5. By Country
Chapter 12. Asia Pacific Vital Signs Monitoring Devices Market Analysis
12.1. Key Insights
12.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
12.2.1. By Measuring Parameters
12.2.2. By Application
12.2.3. By Form Factor
12.2.4. By End User
12.2.5. By Country
Chapter 13. Middle East & Africa Vital Signs Monitoring Devices Market Analysis
13.1. Key Insights
13.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
13.2.1. By Measuring Parameters
13.2.2. By Application
13.2.3. By Form Factor
13.2.4. By End User
13.2.5. By Country
Chapter 14. South America Vital Signs Monitoring Devices Market Analysis
14.1. Key Insights
14.2. Market Size and Forecast, 2017 – 2030 (US$ Mn & 000’Units)
14.2.1. By Measuring Parameters
14.2.2. By Application
14.2.3. By Form Factor
14.2.4. By End User
14.2.5. By Country
Chapter 15. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, Measurement Methods and Business Strategy Outlook)
15.1. A&D Company Ltd.
15.2. Clarity Medical Pvt. Ltd.
15.3. Contec Medical Systems Co. Ltd
15.4. DRE Inc.
15.5. GE Healthcare
15.6. Hill-Rom Holdings, Inc.
15.7. Koninklijke Philips N.V.
15.8. Masimo Corporation
15.9. Mediaid, Inc.
15.10. Medtronic plc.
15.11. Nihon Kohden Corporation
15.12. Nonin Medical Inc.
15.13. Omron Healthcare
15.14. Smiths Group plc.
15.15. SunTech Medical, Inc.
15.16. Other Prominent Players